Ensign Peak Advisors, Inc Otonomy, Inc. Transaction History

Ensign Peak Advisors, Inc

  • $54.2 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 12, 2021
SELL
$2.49 - $6.23 $691,189 - $1.73 Million
-277,586 Closed
0 $0
Q3 2020

Nov 12, 2020
BUY
$3.16 - $4.36 $806,302 - $1.11 Million
255,159 Added 1137.73%
277,586 $1.12 Million
Q1 2020

May 11, 2020
BUY
$1.58 - $4.06 $35,434 - $91,053
22,427 New
22,427 $44,000

About OTONOMY, INC.

OTIC Quotes by TradingView
  • Ticker OTIC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,990,400
  • Description
  • Otonomy, Inc., a biopharmaceutical company, develops therapeutics for neurotology in the United States. The company offers OTO-313, a sustained-exposure formulation of N-methyl-D-aspartate receptor antagonist gacyclidine, which is in Phase II clinical trials to treat tinnitus; and OTO-413, a sustained-exposure formulation of brain-derived neurot...
More about OTIC
Track This Portfolio

Track Ensign Peak Advisors, Inc Portfolio

Follow Ensign Peak Advisors, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ensign Peak Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ensign Peak Advisors, Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email